A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder - sprookjes - yvandenbroek - TriplyDB

A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder

A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder

http://www.wikidata.org/entity/Q33926699

about

Advances in molecular genetic studies of attention deficit hyperactivity disorder in China COMT val158met moderation of dopaminergic drug effects on cognitive function: a critical review Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders Specific Genes Associated with Adverse Events of Methylphenidate Use in the Pediatric Population: A Systematic Literature Review Dopamine transporter genotype and stimulant dose-response in youth with attention-deficit/hyperactivity disorder.Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorder Interactive association of dopamine receptor (DRD4) genotype and ADHD on alcohol expectancies in children.Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder.Polymorphism in variable number of tandem repeats of dopamine d4 gene is a genetic risk factor in attention deficit hyperactive egyptian children: pilot study.Inverse Effect of Fluoxetine on Medial Prefrontal Cortex Activation During Reward Reversal in ADHD and Autism.Variants of Dopamine Beta Hydroxylase Gene Moderate Atomoxetine Response in Children with Attention-Deficit/Hyperactivity Disorder.Human serotonin transporter gene (SLC6A4) variants: their contributions to understanding pharmacogenomic and other functional G×G and G×E differences in health and disease.A Randomized Controlled Trial Investigating the Effects of a Special Extract of Bacopa monnieri (CDRI 08) on Hyperactivity and Inattention in Male Children and Adolescents: BACHI Study Protocol (ANZCTRN12612000827831).Possible effect of norepinephrine transporter polymorphisms on methylphenidate-induced changes in neuropsychological function in attention-deficit hyperactivity disorder.ADHD pharmacogenetics across the life cycle: New findings and perspectives.Should we keep on? Looking into pharmacogenomics of ADHD in adulthood from a different perspective.Evaluating the Hierarchical Structure of ADHD Symptoms and Invariance Across Age and Gender.The marketing of science along with the science of marketing: response to pharmacogenomics of methylphenidate response Meta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHD.Prefrontal AMPA receptors are involved in the effect of methylphenidate on response inhibition in rats.Pharmacogenetics predictors of methylphenidate efficacy in childhood ADHD.DRD4 exon 3 genotype and ADHD: Randomised pharmacodynamic investigation of treatment response to methylphenidate.Pharmacogenomic testing in child and adolescent psychiatry: An evidence-based review.Neurological and Neuropsychological Problems in Tyrosinemia Type I Patients.LPHN3 and attention-deficit/hyperactivity disorder: a susceptibility and pharmacogenetic study.Disorder-dissociated effects of fluoxetine on brain function of working memory in attention deficit hyperactivity disorder and autism spectrum disorder.Val/Val genotype of brain-derived neurotrophic factor (BDNF) Val⁶⁶Met polymorphism is associated with a better response to OROS-MPH in Korean ADHD children.The effects of acute fluoxetine administration on temporal discounting in youth with ADHD.Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder.Exocytosis-related genes and response to methylphenidate treatment in adults with ADHD.Catechol-O-methyltransferase Val158-Met polymorphism and a response of hyperactive-impulsive symptoms to methylphenidate: A replication study from South Korea.Methylphenidate HCL for the treatment of ADHD in children and adolescents.

P2860

Q26995422-B3E24F45-5AF7-4821-A17C-C913CF04B19D Q28074860-8E640C69-0387-4F43-A87B-ECEEC6CFFA28 Q33664787-9B41C707-D4C5-4A89-8178-A864507639C1 Q33777131-00483B13-F951-4593-AD4E-98856F3CE5EE Q33782844-D8BB292F-D410-403D-8BC4-67E21A0F3C2E Q34221423-D61E93AF-416E-49DD-BC96-4A6708059484 Q35088668-617BFBB1-6E36-4D10-ACEF-AE723B86684B Q35575795-333DB8AA-7F31-4036-941E-7431112FDB09 Q35591860-30184FBC-033F-4D0A-84DB-337E374FE541 Q35693662-C9A3D886-B6BE-44AD-9CC0-F7D429CCEECB Q36191809-868C42A0-CD16-4544-9473-0ED9BEF83184 Q36367301-BF914B51-067E-46D9-9F2F-B270A6644515 Q36401245-F041965C-455F-4540-84F1-DBE305C079F2 Q36430286-6195DBC0-8180-4966-8D50-9CD2CB4594E7 Q38209972-F2DECC7F-9509-492C-83DB-49FDD33E399B Q38243174-C29B2DFB-3C9D-4AF3-AF1E-F04E75471F79 Q38722834-AE1EE384-7BEC-428D-BB01-B33785F8F065 Q42785238-6DF328E3-1850-4882-993D-5927AF802CF2 Q44596771-4013B6FF-DAF9-48D3-8CD0-3EDD274B54FB Q47267151-E32901E5-2D0D-4261-94C8-4731787BB66A Q47326953-70F831EE-7BAB-4515-B656-D549B827FCE4 Q47569957-463EA2A6-E22A-4E1F-9642-4C9FBDF3C61D Q47657960-8AFB4B6E-2C9E-4F08-B68C-F78D128B7830 Q47762401-F873A68D-F162-44FB-B254-F93E06EEB72E Q48169800-59017D72-907C-4035-AD9B-F28AB2A0EF6E Q48493702-1EC403E8-56DE-4568-BC1E-421CD61D06BF Q49083889-2099CDD2-ED25-454C-8389-9157CBEACDD6 Q49094157-BA5A78CC-B864-4B1F-820C-0644674AD2FF Q50266015-939337F3-164D-408E-B541-54C797367309 Q50684186-95BC9EA8-93B9-4580-B622-1A7FA0295D90 Q53284859-84DF81BF-253B-417D-A2A6-B45554453DEC Q53736992-E9A3F3EA-64CE-4E79-85D5-F5B9177A6C26

P2860

A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder

http://www.wikidata.org/entity/Q33926699

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

A candidate gene analysis of m ...... deficit/hyperactivity disorder

@ast

A candidate gene analysis of m ...... deficit/hyperactivity disorder

@en

type

label

A candidate gene analysis of m ...... deficit/hyperactivity disorder

@ast

A candidate gene analysis of m ...... deficit/hyperactivity disorder

@en

prefLabel

A candidate gene analysis of m ...... deficit/hyperactivity disorder

@ast

A candidate gene analysis of m ...... deficit/hyperactivity disorder

@en

P1433

Q33926699-5E49A146-22C1-46E3-8AAD-A1A44AB64053

P1476

Q33926699-AFE9824F-E73A-4554-AECC-C1930CC1B804

P2093

Q33926699-0ACB3BF4-2E53-4D36-822B-BC3821706EC7

Q33926699-1249FCFC-ABEB-4B3F-B64F-A2AB9CE061D8

Q33926699-15FA4A5B-BA10-4ADC-AE81-139C6999C808

Q33926699-3171B955-059D-40A4-B6EA-C2B12494B92B

Q33926699-4947529F-61A1-4884-ADF3-0C7EE3C55EEE

Q33926699-524EFDC5-CF75-4B78-83CC-2572AD87AEE3

Q33926699-54DA7F8C-4211-4A70-8590-165286D9CADF

Q33926699-7D367376-9834-47C2-8619-6B100701293D

Q33926699-9F6A768D-8393-4CD4-AA11-32EFD7F410D2

Q33926699-A8C80DA5-D04B-479F-96AB-5A098B9B0BA0

P2860

Q33926699-00341801-D22C-43C2-B982-0807B2CBB663

Q33926699-05CD8471-BBD3-4364-8D0A-98539277F48F

Q33926699-065048D3-5F26-4540-91FC-96AFDF646544

Q33926699-0A550181-023D-457F-A4DB-84FD098632FA

Q33926699-1256EAED-274D-4525-8D1A-1B88E1913EBF

Q33926699-2328594C-D79A-4651-8FC0-74ABC73D4FBC

Q33926699-236995AE-263A-4344-AF4E-828BA3F68FA7

Q33926699-2B4973DA-5F0D-4F4A-AD39-FFEAA8C4CC27

Q33926699-2E62E20C-C5BC-4AA8-8F70-3F44B39AB1B2

Q33926699-304BFF23-E261-4A44-9652-437B6060E6E6

P304

Q33926699-E5BE6E6D-CF58-453B-88DF-15ABF12F372F

P31

Q33926699-10B4B3D7-2105-4BBE-85B1-4D74CA1AE559

P356

Q33926699-FE4CCE0A-6478-4467-A848-FE00AE2BE8DA

P433

Q33926699-C8FE5281-3FB9-491E-9511-3A79C5294C85

P478

Q33926699-7330EB7B-3AB2-478B-95CA-701FC42FD455

P577

Q33926699-803358A8-03E5-4384-A248-7544FA020FAE

P5875

Q33926699-D4F1650E-8917-4D03-93DD-F677845D3DA6

P698

Q33926699-67E63529-4091-4B9F-92CF-F18AA5415368

P921

Q33926699-DB322A08-45F1-4D30-A99F-14182354F657

P932

Q33926699-611A2382-7F96-4C45-8D95-337B44ED5D43

P356

CHI.0B013E3181BC72E3

P1433

Journal of the American Academy of Child and Adolescent Psychiatry

P1476

A candidate gene analysis of m ...... deficit/hyperactivity disorder

@en

P2093

Catherine A Sugar

http://www.w3.org/2001/XMLSchema#string

Gerhard Hellemann

http://www.w3.org/2001/XMLSchema#string

James J McGough

http://www.w3.org/2001/XMLSchema#string

James T McCracken

http://www.w3.org/2001/XMLSchema#string

Jeremy R Tietjens

http://www.w3.org/2001/XMLSchema#string

Marc Manganiello

http://www.w3.org/2001/XMLSchema#string

Michael C Leung

http://www.w3.org/2001/XMLSchema#string

Robert Suddath

http://www.w3.org/2001/XMLSchema#string

Sandra K Loo

http://www.w3.org/2001/XMLSchema#string

Shilpa Baweja

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD

Systematic search for variation in the human norepinephrine transporter gene: identification of five naturally occurring missense mutations and study of association with major psychiatric disorders

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11

Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate.

Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder.

Molecular genetics of attention-deficit/hyperactivity disorder.

Attention-deficit/hyperactivity disorder pharmacogenomics.

Attention-deficit/hyperactivity disorder: advancing on pharmacogenomics.

The pharmacogenomic era: promise for personalizing attention deficit hyperactivity disorder therapy.

P304

1155-1164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/CHI.0B013E3181BC72E3

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38038082

http://www.w3.org/2001/XMLSchema#string

P698

19858760

http://www.w3.org/2001/XMLSchema#string

P921

P932

2888980

http://www.w3.org/2001/XMLSchema#string